UBS Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-200
Closed -$28K – 9293
2020
Q4
$28K Hold
200
– – ﹤0.01% 6692
2020
Q3
$22K Hold
200
– – ﹤0.01% 6239
2020
Q2
$19K Sell
200
-100
-33% -$8.51K ﹤0.01% 6590
2020
Q1
$22K Sell
300
-200
-40% -$17.4K ﹤0.01% 6436
2019
Q4
$42K Buy
+500
New +$38.7K ﹤0.01% 6445

Other funds holding MEDP

UBS Group's MEDP Position: Q3 2026 in Review

UBS Group reduced its Medpace (MEDP) stake by 62% in Q3 2026, selling an estimated $110M and leaving 116,114 shares worth $72.5M. The position accounts for 0.01% of the portfolio, ranked #1350.

UBS Group first reported a position in MEDP in Q3 2016 and has held it in 41 quarters since. The position peaked at $185M in Q4 2025. 762 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • UBS Group held 116,114 shares of Medpace worth $72.5M as of Q3 2026.
  • UBS Group sold 187,812 Medpace shares in Q3 2026, an estimated $110M.
  • Medpace made up 0.01% of UBS Group's portfolio in Q3 2026, its #1350 holding.
  • UBS Group first reported a position in Medpace in Q3 2016 and has held it in 41 quarters since.
  • UBS Group's Medpace position peaked at $185M in Q4 2025.
  • 762 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.